UK Product Safety Review Power Briefing Webinar

Join Cooley’s International Products Team for a 30 minute overview and discussion of the key proposals contained in the UK’s long awaited Product Safety Review and their potential impact on those doing business in the UK.

European Commission Publishes Guidance on Transition from Clinical Trials Directive to Clinical Trials Regulation

Elizabeth Anne Wright , Jessica Lauren Koffel and Alix Vermulst

On 19 July 2023, the European Commission published a guidance document concerning the steps to be taken in the transition of clinical trials from the Clinical Trials Directive (CTD) to the Clinical Trials Regulation (CTR).

European Commission Publishes Its Proposed New Toy Safety Regulation

Edward Turtle and
Tracey Bischofberger

The European Commission published its legislative proposal to revise the Toy Safety Directive on 28 July 2023. This long-awaited proposal follows the evaluation of the Toy Safety Directive published in 2020 that identified a number of areas where it was thought that the existing rules could be strengthened. The draft legislation includes proposed reforms we expect could influence other European Union sector-specific product rules, such as proposed requirements for a Digital Product Passport to provide certain compliance information.

European Commission Publishes MDR and IVDR Factsheet for Non-EU/EEA Countries

Elizabeth Anne Wright , Jessica Lauren Koffel and Alix Vermulst

On 12 July 2023, the European Commission published a factsheet for authorities outside the European Union (EU) and the European Economic Area (EEA) on the implications of the extended deadlines in Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR).

UK Government Provides Limited Extensions to Recognition of CE Marks for Medical Devices in Great Britain 

Elizabeth Anne Wright , Jessica Lauren Koffel and Alix Vermulst

On 1 August 2023, the UK government announced plans to extend recognition of CE marking ‘indefinitely’ for certain products placed on the Great Britain market (England, Wales and Scotland).

UK Product Safety Review Finally Published – and Contains Some Surprises

Claire Temple , Ed Turtle , Rod Freeman and Tracey Bischofberger

On 2 August 2023, the UK government published its long-awaited proposals for reform of the UK product safety regime. There are 13 wide-ranging proposals, some of which could radically change the UK product safety landscape and/or have a significant impact for stakeholders.

UK Government Announces ‘Indefinite’ Extension of CE Marking Recognition for 18 Categories of Goods

Rod Freeman , Claire Temple , Edward Turtle and Tracey Bischofberger

On the 1st August the UK government announced plans to extend recognition of CE marking ‘indefinitely’ beyond the upcoming December 2024 legislative deadline for certain products placed on the Great Britain market (England, Wales and Scotland).   This announcement means that the UK Conformity Assessed (UKCA) mark will no longer be required on many products, which is a significant change of position from the UK government. The details – including how divergence will be accommodated – are not yet clear, so there are a number of unanswered questions. However, read on for what we know so far.  

European Parliament Adopts Negotiating Mandate on Ecodesign for Sustainable Products Regulation

Emma Bichet and Fergal Duggan

We are one step closer to adoption of the European Union’s new Ecodesign for Sustainable Products Regulation, which is set to have a big impact on several groups of consumer products, as well as intermediates, such as chemicals, iron, steel and aluminium.

EU Batteries Regulation Passes Final Vote

Julia Greaves and Edward Turtle

On 10 July 2023, the European Council voted to approve the Batteries Regulation text. This is the final legislative hurdle for the Batteries Regulation, which will now be translated, signed and published in the Official Journal of the European Union (OJEU) in the next few weeks. The regulation will enter into force 20 days after publication in the OJEU, with the clock beginning to run on a number of important transition periods from that date.

GCP Q&A Clarifies Sponsor Role in Trial-Related Tasks, Provides Other Updates

The European Medicines Agency (EMA) has updated its Q&A for good clinical practice (GCP). The update acknowledges that the sponsor may support the investigator by identifying or contracting service providers in the conduct of the clinical trial. This update reflects the leading role of sponsors in interaction with contracting service […]